Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
- Conditions
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2014-06-24
- Lead Sponsor
- University of Leicester
- Target Recruit Count
- 316
- Registration Number
- NCT00053872
- Locations
- 🇫🇷
Institut Curie Hopital, Paris, France
🇩🇪Universitaets - Kinderklinik Wuerzburg, Wuerzburg, Germany
🇳🇱Academisch Medisch Centrum at University of Amsterdam, Amsterdam, Netherlands
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- Conditions
- First Posted Date
- 2003-01-28
- Last Posted Date
- 2009-07-07
- Lead Sponsor
- Theradex
- Registration Number
- NCT00053105
- Locations
- 🇺🇸
Arizona Clinical Research Center, Tucson, Arizona, United States
🇺🇸Highlands Oncology Group, Springdale, Arkansas, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
- Conditions
- Ovarian Embryonal CarcinomaStage IIC Ovarian Germ Cell TumorStage III Malignant Testicular Germ Cell TumorStage IIIA Ovarian Germ Cell TumorChildhood Embryonal TumorChildhood Extracranial Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Malignant Testicular Germ Cell TumorChildhood TeratomaOvarian Yolk Sac Tumor
- Interventions
- First Posted Date
- 2003-01-28
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 302
- Registration Number
- NCT00053352
- Locations
- 🇺🇸
West Virginia University Charleston, Charleston, West Virginia, United States
🇺🇸Geisinger Medical Center, Danville, Pennsylvania, United States
🇺🇸Children's Hospital Central California, Madera, California, United States
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 671
- Registration Number
- NCT00045162
- Locations
- 🇺🇸
Northside Hospital Cancer Center, Atlanta, Georgia, United States
🇺🇸Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, United States
🇺🇸MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States
Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
- Conditions
- Stage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Squamous Cell Carcinoma of the OropharynxStage IV Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Squamous Cell Carcinoma of the Oropharynx
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-30
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 48
- Registration Number
- NCT00049166
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00006004
- Locations
- 🇵🇪
Instituto de Enfermedades Neoplasicas, Lima, Peru
🇺🇸Mercy Medical Center, Des Moines, Iowa, United States
🇺🇸Iowa Methodist Medical Center, Des Moines, Iowa, United States
Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 800
- Registration Number
- NCT00002894
- Locations
- 🇬🇧
Middlesex Hospital- Meyerstein Institute, London, England, United Kingdom
Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- National Cancer Centre, Singapore
- Target Recruit Count
- 200
- Registration Number
- NCT00003637
- Locations
- 🇸🇬
National Cancer Centre - Singapore, Singapore, Singapore
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 500
- Registration Number
- NCT00002615
- Locations
- 🇬🇧
Epsom General Hospital, Epsom, Surrey, United Kingdom
Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-09-24
- Target Recruit Count
- 3
- Registration Number
- NCT00014313
- Locations
- 🇬🇧
Institute of Cancer Research - UK, Sutton, England, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.